Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma. (Q43837285)
Jump to navigation
Jump to search
scientific article published in October 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma. |
scientific article published in October 2001 |
Statements
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma (English)
D Machover
B Delmas-Marsalet
Y Gumus
E Goldschmidt
A Schilf
N Frénoy
J F Emile
B Debuire
C Guettier
P Farrokhi
B Boulefdaoui
F Norol
N Parquet
A Ulusakarya